87 related articles for article (PubMed ID: 24634158)
1. Evaluation of a (99m) Tc-labelled meso-bisphenylporphyrin as a tumour image agent.
Santos PM; Laranjo M; Serra AC; Abrantes AM; Piñeiro M; Casalta-Lopes J; Trindade D; Maia J; Rocha-Gonsalves A; Botelho MF
J Labelled Comp Radiopharm; 2014 Mar; 57(3):141-7. PubMed ID: 24634158
[TBL] [Abstract][Full Text] [Related]
2. (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.
Ananias HJ; Yu Z; Dierckx RA; van der Wiele C; Helfrich W; Wang F; Yan Y; Chen X; de Jong IJ; Elsinga PH
Mol Pharm; 2011 Aug; 8(4):1165-73. PubMed ID: 21699202
[TBL] [Abstract][Full Text] [Related]
3. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary biological evaluation of the first (99m)Tc(I)-specific semi-rigid tridentate ligand based on a click chemistry strategy.
Guizani S; Malek Saied N; Picard C; Benoist E; Saidi M
J Labelled Comp Radiopharm; 2014 Mar; 57(3):158-63. PubMed ID: 24425684
[TBL] [Abstract][Full Text] [Related]
5. Preparation and biological evaluation of (99m) TcN-labeled pteroyl-lys derivative as a potential folate receptor imaging agent.
Chen Y; Guo H; Xie F; Lu J
J Labelled Comp Radiopharm; 2014 Jan; 57(1):12-7. PubMed ID: 24448741
[TBL] [Abstract][Full Text] [Related]
6. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
7. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A
Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883
[TBL] [Abstract][Full Text] [Related]
8. Preparation, 99mTc-labeling and biodistribution studies of a PNA oligomer containing a new ligand derivative of 2,2'-dipicolylamine.
Gasser G; Jäger K; Zenker M; Bergmann R; Steinbach J; Stephan H; Metzler-Nolte N
J Inorg Biochem; 2010 Nov; 104(11):1133-40. PubMed ID: 20674031
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of (99m)Tc-2-[(3-carboxy-1-oxopropyl)amino]-2-deoxy-D-glucose as a potential tumor imaging agent.
Wang Y; Zhu J; Song X; Wang X; Yang J; Zhang J
Bioorg Med Chem Lett; 2014 Aug; 24(16):3882-5. PubMed ID: 25001483
[TBL] [Abstract][Full Text] [Related]
10. Preliminary studies of (99m)Tc-memantine derivatives for NMDA receptor imaging.
Zhou X; Zhang J; Yan C; Cao G; Zhang R; Cai G; Jiang M; Wang S
Nucl Med Biol; 2012 Oct; 39(7):1034-41. PubMed ID: 22516779
[TBL] [Abstract][Full Text] [Related]
11. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and imaging of small amphiphilic rhenium and (99m)technetium tricarbonyl complexes.
Boros E; Häfeli UO; Patrick BO; Adam MJ; Orvig C
Bioconjug Chem; 2009 May; 20(5):1002-9. PubMed ID: 19341277
[TBL] [Abstract][Full Text] [Related]
13. Technetium glucose complexes as potential cancer imaging agents.
Dapueto R; Aguiar RB; Moreno M; Machado CM; Marques FL; Gambini JP; Chammas R; Cabral P; Porcal W
Bioorg Med Chem Lett; 2015 Oct; 25(19):4254-9. PubMed ID: 26318991
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of labelled small peptide complexes for imaging agents with technetium-99m and biodistribution in mice.
Qi CM; Guo XF; Zhang HB; Li B; Jin W; Dai M
Yao Xue Xue Bao; 2002 Jul; 37(7):522-6. PubMed ID: 12914321
[TBL] [Abstract][Full Text] [Related]
15. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy.
Subbarayan M; Häfeli UO; Feyes DK; Unnithan J; Emancipator SN; Mukhtar H
J Nucl Med; 2003 Apr; 44(4):650-6. PubMed ID: 12679412
[TBL] [Abstract][Full Text] [Related]
16. Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):16-23. PubMed ID: 17372569
[TBL] [Abstract][Full Text] [Related]
17. Anti-MUC1 aptamers: radiolabelling with (99m)Tc and biodistribution in MCF-7 tumour-bearing mice.
Pieve CD; Perkins AC; Missailidis S
Nucl Med Biol; 2009 Aug; 36(6):703-10. PubMed ID: 19647177
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
[TBL] [Abstract][Full Text] [Related]
19. A novel [186/188Re]-labelled porphyrin for targeted radiotherapy.
Banerjee S; Das T; Samuel G; Sarma HD; Venkatesh M; Pillai MR
Nucl Med Commun; 2001 Oct; 22(10):1101-7. PubMed ID: 11567183
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99 m labeling and evaluation of olsalazine: a novel agent for ulcerative colitis imaging.
El-Kawy OA; Ibrahim IT; Farah K
J Labelled Comp Radiopharm; 2015 Jun; 58(8):336-41. PubMed ID: 26031480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
